New Strong Buy Stocks for December 26th

Zacks
26 Dec 2024

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:

eGain Corporation EGAN: This customer engagement solutions provider has seen the Zacks Consensus Estimate for its current year earnings increasing 27.8% over the last 60 days.

eGain Corporation Price and Consensus

eGain Corporation price-consensus-chart | eGain Corporation Quote

ACM Research, Inc. ACMR: This semiconductor cleaning equipment provider has seen the Zacks Consensus Estimate for its current year earnings increasing 18.4% over the last 60 days.

ACM Research, Inc. Price and Consensus

ACM Research, Inc. price-consensus-chart | ACM Research, Inc. Quote

Mission Produce, Inc. AVO: This agribusiness company has seen the Zacks Consensus Estimate for its current year earnings increasing 44.8% over the last 60 days.

Mission Produce, Inc. Price and Consensus

Mission Produce, Inc. price-consensus-chart | Mission Produce, Inc. Quote

BlackBerry Limited BB: This intelligent security software and services provider has seen the Zacks Consensus Estimate for its current year earnings increasing 150% over the last 60 days.

BlackBerry Limited Price and Consensus

BlackBerry Limited price-consensus-chart | BlackBerry Limited Quote

NRx Pharmaceuticals, Inc. NRXP: This bio-pharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 46.2% over the last 60 days.

NRx Pharmaceuticals, Inc. Price and Consensus

NRx Pharmaceuticals, Inc. price-consensus-chart | NRx Pharmaceuticals, Inc. Quote

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here. 

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

ACM Research, Inc. (ACMR) : Free Stock Analysis Report

eGain Corporation (EGAN) : Free Stock Analysis Report

BlackBerry Limited (BB) : Free Stock Analysis Report

Mission Produce, Inc. (AVO) : Free Stock Analysis Report

NRx Pharmaceuticals, Inc. (NRXP) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10